池田 直也 いけだ なおや 先生

来歴等

略歴

1992年 奈良県立医科大学 卒業
2001年 奈良県立医科大学 第一外科 助手
2006年 奈良県立三室病院 外科 部長
2014年 奈良県西和医療センター 外科 部長
2014年 奈良県立医科大学 臨床教授
2017年 奈良県立医科大学消化器・総合外科 准教授

論文

• Simple technique for gasless transumbilical single-incisional laparoscopic-assisted appendectomy. Langenbecks Arch Surg. 399. 675-676. 2014

  Ikeda N. Reply to the letter to the editor.

• Ikeda N, Ueno M, Kanamura T, Sho M, Sasaki Y, Enomoto K, Kunishige T, Nogi K, Kosugi T, Nakagawa K, Sakaguchi H, Hidaka S, Ochi T, Nakajima Y. Simple technique for gasless transumbilical single-incisional laparoscopic-assisted appendectomy. Langenbecks Arch Surg. 399. 359-366. 2014

• Safety and feasibility for single-incision laparoscopic cholecystectomy in local community hospital: a retrospective comparison with conventional 4-port laparoscopic cholecystectomy. Surg Laparosc Endosc Percutan Tech. 23. 33-36. 2013

  Ikeda N, Ueno M, Kanamura T, Kojima Y, Nakagawa K, Ishioka K, Sasaki Y, Sho M, Sakaguchi H, Hidaka S, Ochi T, Nakajima Y.

• Clinical significance of aminopeptidase N/CD13 expression in human pancreatic carcinoma. Clin Cancer Res. 9. 1503-1508. 2003

  Ikeda N, Nakajima Y, Tokuhara T, Hattori N, Sho M, Kanehiro H, Miyake M.

• The association of K-ras gene mutation and vascular endothelial growth factor gene expression in pancreatic carcinoma. Cancer. 92. 488-499. 2001

  Ikeda N, Nakajima Y, Sho M, Adachi M, Huang CL, Iki K, Kanehiro H, Hisanaga M, Nakano H, Miyake M.

• Prognostic significance of angiogenesis in human pancreatic cancer. Br J Cancer. 79. 1553-1563. 1999

  Ikeda N, Adachi M, Taki T, Huang C, Hashida H, Takabayashi A, Sho M, Nakajima Y, Kanehiro H, Hisanaga M, Nakano H, Miyake M.

• Ohbayashi C, Kichikawa K, Ikeda N. Significance of the inflammation-based prognostic score in recurrent pancreatic cancer. Pancreatology. 2019 Jul;19(5):722-728. doi: 10.1016/j.pan.2019.05.461. Epub 2019 May 23.

  Nakagawa K, Sho M, Akahori T, Nagai M, Nakamura K, Takagi T, Tanaka T, Nishiofuku H,

• Role of Metastasis-Related Genes in Cisplatin Chemoresistance in Gastric Cancer. Int J Mol Sci. 2019 Dec 30;21(1):254. doi: 10.3390/ijms21010254.

  Nishiguchi Y, Oue N, Fujiwara-Tani R, Sasaki T, Ohmori H, Kishi S, Mori S, Mori T, Ikeda N, Matsumoto S, Wakatsuki K, Luo Y, Yasui W, Sho M, Kuniyasu H.

• Phase II Study of the Triple Combination Chemotherapy of SOXIRI (S-1/Oxaliplatin/Irinotecan) in Patients with Unresectable Pancreatic Ductal Adenocarcinoma. Oncologist. 2019 Jun;24(6):749-e224. doi: 10.1634/theoncologist.2018-0900. Epub 2019 Jan 24.

  Akahori T, Sho M, Yanagimoto H, Satoi S, Nagai M, Nishiwada S, Nakagawa K, Nakamura K, Yamamoto T, Hirooka S, Yamaki S, Ikeda N.

• A Comparison Between Plastic and Metallic Biliary Stent Placement in Patients Receiving Preoperative Neoadjuvant Chemoradiotherapy for Resectable Pancreatic Cancer. World J Surg. 2019 Feb;43(2):642-648. doi: 10.1007/s00268-018-4820-6.

  Nakamura K, Sho M, Akahori T, Nagai M, Nishiwada S, Nakagawa K, Tanaka T, Kichikawa K, Tamamoto T, Hasegawa M, Mitoro A, Yoshiji H, Ikeda N.

• Risk Factors for Late-Onset Gastrointestinal Hemorrhage After Pancreatoduodenectomy for Pancreatic Cancer. World J Surg. 2019 Feb;43(2):626-633. doi: 10.1007/s00268-018-4791-7.

  Nagai M, Sho M, Akahori T, Nishiwada S, Nakagawa K, Nakamura K, Tanaka T, Nishiofuku H, Kichikawa K, Ikeda N.

• Prognostic factors for actual long- term survival in the era of multidisciplinary treatment for pancreatic ductal adenocarcinoma. Langenbecks Arch Surg. 2018 Sep;403(6):693-700. doi: 10.1007/s00423-018-1709-7. Epub 2018 Sep 15

  Nakagawa K, Akahori T, Nishiwada S, Nagai M, Nakamura K, Tanaka T, Tamamoto T, Ohbayashi C, Hasegawa M, Kichikawa K, Ikeda N, Sho M.

• Significance of bacterial culturing of prophylactic drainage fluid in the early postoperative period after liver resection for predicting the development of surgical site infections. Surg Today. 2018 Jun;48(6):625-631. doi: 10.1007/s00595-018-1629-8. Epub 2018 Jan 29.

  Ishioka K, Hokuto D, Nomi T, Yasuda S, Yoshikawa T, Matsuo Y, Akahori T, Nishiwada S, Nakagawa K, Nagai M, Nakamura K, Ikeda N, Sho M.

• Effects of pancrelipase on nonalcoholic fatty liver disease after pancreaticoduodenectomy. J Hepatobiliary Pancreat Sci. 2014 Mar;21(3):186-92. doi: 10.1002/jhbp.14. Epub 2013 Jun 20.

  Nagai M, Sho M, Satoi S, Toyokawa H, Akahori T, Yanagimoto H, Yamamoto T, Hirooka S, Yamaki S, Kinoshita S, Nishiwada S, Ikeda N, Kwon AH, Nakajima Y.

• Do pancrelipase delayed-release capsules have a protective role against nonalcoholic fatty liver disease after pancreatoduodenectomy in patients with pancreatic cancer? A randomized controlled trial. J Hepatobiliary Pancreat Sci. 23. 167-173. 2016

  Satoi S, Sho M, Yanagimoto H, Yamamoto T, Akahori T, Kinoshita S, Nagai M, Hirooka S, Yamaki S, Nishiwada S, Ryota H, Ikeda N, Nakajima Y, Kon M.

• Phase I study assessing the feasibility of the triple combination chemotherapy of SOXIRI (S-1/oxaliplatin/irinotecan) in patients with unresectable pancreatic ductal adenocarcinoma.. Cancer Chemother Pharmacol. 77. 35-41. 2016

  Yanagimoto H, Satoi S, Sho M, Akahori T, Yamamoto T, Hirooka S, Yamaki S, Kotsuka M, Ryota H, Kinoshita S, Nishiwada S, Nagai M, Ikeda N, Tsuta K, Nakajima Y, Kon M.

• Central Pancreatectomy with Double Pancreaticojejunostomy. J Am Coll Surg. 221. 15-19. 2015

  Sho M, Akahori T, Nagai M, Satoi S, Yanagimoto H, Kinoshita S, Yamamoto T, Ikeda N, Kwon AH, Nakajima Y.

• Potential role of surgical resection for pancreatic cancer in the very elderly. Pancreatology. 15. 240-246. 2015

  Kinoshita S, Sho M, Yanagimoto H, Satoi S, Akahori T, Nagai M, Nishiwada S, Yamamoto T, Hirooka S, Yamaki S, Ikeda N, Kwon AH, Nakajima Y.

• Effects of pancrelipase on nonalcoholic fatty liver disease after pancreaticoduodenectomy. J Hepatobiliary Pancreat Sci. 21. 186-192. 2014

  Nagai M, Sho M, Satoi S, Toyokawa H, Akahori T, Yanagimoto H, Yamamoto T, Hirooka S, Yamaki S, Kinoshita S, Nishiwada S, Ikeda N, Kwon AH, Nakajima Y.

• A comparison of epidermal growth factor receptor expression in malignant peritoneal and pleural mesothelioma. Pathol Int. 62. 226-231. 2012

  Enomoto Y, Kasai T, Takeda M, Takano M, Morita K, Kadota E, Iizuka N, Maruyama H, Haratake J, Kojima Y, Ikeda N, Nonomura A.

• Epidermal growth factor receptor mutations in malignant pleural and peritoneal mesothelioma. J Clin Pathol. 65. 522-527. 2012

  Enomoto Y, Kasai T, Takeda M, Takano M, Morita K, Kadota E, Iizuka N, Maruyama H, Haratake J, Kojima Y, Ikeda N, Inatsugi N, Nonomura A.

• Primary leiomyoma of the liver: report of a case.　Surg Today. 36. 629-632. 2006

  Urizono Y, Ko S, Kanehiro H, Hisanaga M, Aomatsu Y, Nagao M, Ikeda N, Yamada T, Nakajima Y.

• A potent antiangiogenic factor, endostatin prevents the development of asthma in a murine model. J Allergy Clin Immunol. 116. 1220-1227. 2005

  Suzaki Y, Hamada K, Sho M, Ito T, Miyamoto K, Akashi S, Kashizuka H, Ikeda N, Nakajima Y, Iwase M, Homma I, Kobzik L, Kimura H.

• Function of the Vascular Endothelial Growth Factor Receptors Flt-1 and Flk-1/KDR in the Alloimmune Response In Vivo. Transplantation. 80. 717-722. 2005

  Sho M, Akashi S, Kanehiro H, Hamada K, Kashizuka H, Ikeda N, Nomi T, Kuzumoto Y, Tsurui Y, Yoshiji H, Wu Y, Hicklin DJ, Briscoe DM, Nakajima Y.

• Significance and therapeutic potential of prostaglandin E2 receptor in hepatic ischemia/reperfusion injury in mice. Hepatology. 42. 608-617. 2005

  Kuzumoto Y, Sho M, Ikeda N, Hamada K, Mizuno T, Akashi S, Tsurui Y, Kashizuka H, Nomi T, Kubo A, Kanehiro H, Nakajima Y.

• 乳癌-乳癌診療ガイドライン2018の改訂の概要- 日本外科学会雑誌， 121，3号，p370-371, 2020年

  池田直也

• 腹腔鏡下手術の進歩―単孔式手術について 奈良県医師会医学会年報26（1）p1-7, 2013

  池田直也

著書

• Naoya Ikeda, Masayuki Sho, Masayuki Miyake, Yoshiyuki Nakajima Molecular alterations involved in prognosis in pancreatic carcinoma Shigeki Kuriyama, Hitoshi Yoshiji New Perspectives in Cancer Research and Therapy, Kerala, India: RESEARCH SIGNPOST; pp247-259, 2005.

• 【共著】池田直也, 庄雅之, 堤雅弘, 三宅正幸、中島祥介.多変量解析による膵癌の進展・予後に関与する遺伝子異常の検索　 病理と臨床. 文光堂 819-825. 2004

その他

• 【受賞】平成13年度奈良県医師会学術奨励賞受賞

• 【受賞】第30回日本内視鏡外科学会総会ePoster Award受賞

SNS・ブログ等

• その他メディア
  • 本医師との医学的知識共同研究をご希望の企業は、下記のURLからお問い合わせください。